Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation

Europace

Volumn 16, Issue 12, 2014, Pages 1731-1737

  Canpolat, Uǧur ^a   Aytemir, Kudret ^b   Yorgun, Hikmet ^b   Şahiner, Levent ^b   Kaya, Ergün Bariş ^b   Çay, Serkan ^a   Topaloǧlu, Serkan ^a   Aras, Dursun ^a   Oto, Ali ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Catheter ablation; Recurrence; Uric acid

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTERY DIAMETER; ARTICLE; CATHETER ABLATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOABLATION; CRYOBALLOON BASED CATHETER ABLATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PAROXYSMAL ATRIAL FIBRILLATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; URIC ACID BLOOD LEVEL; ATRIAL FIBRILLATION; BLOOD; CRYOSURGERY; HEART CATHETERIZATION; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; CRYOSURGERY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URIC ACID;

EID: 84933576675     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu198     Document Type: Article

References (17)

1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
2. Oto A, Aytemir K, Canpolat U, Karakulak U, Evranos B, Sahiner L et al. [Pulmonary vein isolation with the cryoballoon technique in atrial fibrillation treatment: single centre experience]. Turk Kardiyol Dern Ars 2013;41:299-309.
3. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
4. Letsas KP,Weber R, Burkle G, Mihas CC, Minners J, Kalusche D et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace 2009;11:158-63.
5. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
6. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-49.
7. Huang CX, Liu Y, XiaWF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009;72:466-7.
8. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005;11:4145-51.
9. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD et al. Uric acid and inflammatory markers. Eur Heart J 2006;27:1174-81.
10. Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P et al. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol 2013;62:72-9.
11. Smit MD, Maass AH, De Jong AM, Muller Kobold AC, Van Veldhuisen DJ, Van Gelder IC. Role of inflammation in early atrial fibrillation recurrence. Europace 2012;14:810-7.
12. Arya A, Hindricks G, Sommer P, Huo Y, Bollmann A, Gaspar T et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 2010;12:173-80.
13. Bitter T, Nolker G, Vogt J, Prinz C, Horstkotte D, Oldenburg O. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing. J Cardiovasc Electrophysiol 2012; 23:18-25.
14. D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation? a meta-analysis. Int J Cardiol 2013;167:1984-9.
15. He XN, Li SN, Zhan JL, Xie SL, Zhang ZJ, Dong JZ et al. Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation. Chin Med J (Engl) 2013;126:860-4.
16. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46.
17. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A et al. Personalized management of atrial fibrillation: proceedings from the fourth atrial fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013;15:1540-56.